Basit öğe kaydını göster

dc.contributor.authorKosar, F.
dc.contributor.authorUysal, Pınar
dc.contributor.authorYIGITBAS, B. A.
dc.contributor.authorErman, H.
dc.contributor.authorUzun, Hafize
dc.contributor.authorYurt, S.
dc.contributor.authorKorkmaz, G. G.
dc.date.accessioned2021-03-05T09:33:55Z
dc.date.available2021-03-05T09:33:55Z
dc.date.issued2015
dc.identifier.citationUysal P., Yurt S., Erman H., Korkmaz G. G. , YIGITBAS B. A. , Kosar F., Uzun H., "THE ROLE OF CHITOTRIOSIDASE ACTIVITY AS A PROGNOSTIC BIOMARKER IN SARCOIDOSIS", ACTA MEDICA MEDITERRANEA, cilt.31, ss.1223-1228, 2015
dc.identifier.issn0393-6384
dc.identifier.othervv_1032021
dc.identifier.otherav_9e68ed48-b9d1-408c-b75f-9443d3a8ebc2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/106387
dc.description.abstractIntroduction: Chitotriosidase (ChT) is a chitinase that is massively expressed by lipid-laden tissue macrophages in human beings. The aim of this study was to compare ChT activities in the serum and bronchoalveolar lavage (BAL) fluid and serum ChT levels with serum angiotensin converting enzyme (ACE) levels in patients with newly diagnosed pulmonary sarcoidosis (SARC), pulmonary tuberculosis (TB) and interstitial lung disease (ILD), all of which create difficulties in the differential diagnosis in daily practice.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleTHE ROLE OF CHITOTRIOSIDASE ACTIVITY AS A PROGNOSTIC BIOMARKER IN SARCOIDOSIS
dc.typeMakale
dc.relation.journalACTA MEDICA MEDITERRANEA
dc.contributor.departmentIstanbul Yedikule Chest Diseases & Thoracic Surgery Training & Research Hospital , ,
dc.identifier.volume31
dc.identifier.issue6
dc.identifier.startpage1223
dc.identifier.endpage1228
dc.contributor.firstauthorID19382


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster